Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by topic
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by topic
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
topic
Journal for ImmunoTherapy of Cancer
Special collections
JITC
Commentary/Editorials
Email alerts
Commentary/Editorials
Special collections
/
JITC
/
Commentary/Editorials
When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report
Marie-Léa
Gauci
,
Barouyr
Baroudjian
,
Celeste
Lebbe
,
Olivier
Roux
Journal for ImmunoTherapy of Cancer
Mar 2021,
9
(3)
e002337;
DOI:
10.1136/jitc-2021-002337
Extending the conversation over the immune-related hepatotoxicity: author response to Dr. Gauci
et al
Dimitrios C
Ziogas
,
Helen
Gogas
Journal for ImmunoTherapy of Cancer
Mar 2021,
9
(3)
e002391;
DOI:
10.1136/jitc-2021-002391
Letter to the editor: Hypoxia kinetics and histology in combined radiotherapy and oxidative phosphorylation inhibition effects on antitumor immunity
Daan F
Boreel
,
Paul N
Span
,
Johan
Bussink
Journal for ImmunoTherapy of Cancer
Mar 2021,
9
(3)
e001793;
DOI:
10.1136/jitc-2020-001793
Perspectives on COVID-19 and cancer immunotherapy: a review series
Jason D
Goldman
,
Paolo Antonio
Ascierto
Journal for ImmunoTherapy of Cancer
Mar 2021,
9
(3)
e002489;
DOI:
10.1136/jitc-2021-002489
Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis
Margaret
Gatti-Mays
,
James L
Gulley
Journal for ImmunoTherapy of Cancer
Feb 2021,
9
(2)
e002252;
DOI:
10.1136/jitc-2020-002252
Immune checkpoint inhibitor-related hypogonadism and infertility: a neglected issue in immuno-oncology
Berna C
Özdemir
Journal for ImmunoTherapy of Cancer
Feb 2021,
9
(2)
e002220;
DOI:
10.1136/jitc-2020-002220
Letter to the editor: Checking the pulse of adoptive cell therapy for solid tumors. Thoughts from the abstracts submitted to the 35th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2020)
Martina
Markovska
,
Francesco
Marincola
Journal for ImmunoTherapy of Cancer
Jan 2021,
9
(1)
e002216;
DOI:
10.1136/jitc-2020-002216
Complement controls the immune synapse and tumors control complement
Alan
Herbert
Journal for ImmunoTherapy of Cancer
Dec 2020,
8
(2)
e001712;
DOI:
10.1136/jitc-2020-001712
Management of immune checkpoint therapy for patients with cancer in the face of COVID-19
Chen
Shen
,
Qianru
Li
,
Yongchang
Wei
,
Yuting
Li
,
Jun
Li
,
Juan
Tao
Journal for ImmunoTherapy of Cancer
Dec 2020,
8
(2)
e001593;
DOI:
10.1136/jitc-2020-001593
Microbiome-derived metabolome as a potential predictor of response to cancer immunotherapy
Agnieszka Beata
Malczewski
,
Severine
Navarro
,
Jermaine IG
Coward
,
Natkunam
Ketheesan
Journal for ImmunoTherapy of Cancer
Oct 2020,
8
(2)
e001383;
DOI:
10.1136/jitc-2020-001383
Pages
1
2
3
4
5
6
7
8
9
next ›
last »
Special collections
COVID-19
(21)
Editor's choice
JITC
Basic Tumor Immunology
(261)
Case Reports
(171)
Clinical Trials Monitor
(13)
Clinical/Translational Cancer Immunotherapy
(474)
Commentary/Editorials
(90)
COVID-19 and Cancer Immunotherapy
(4)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(26)
Guidelines and Consensus Statements
(25)
Immune Cell Therapies and Immune Cell Engineering
(47)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(176)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(34)
Reviews
(143)
Open access
(1573)
Press releases
